Study offers a comprehensive analysis of bacterial and fungal alterations in COVID-19

FHS
July 24, 2023
9:17 am

Researchers use nanopore sequencing to determine the fungal and bacterial microbiota in the lungs of COVID-19 and non-COVID-19 patients.

J&J’s multiple myeloma therapies drive oncology business despite slow Carvykti sales

Johnson & Johnson defended slower-than-expected sales of Carvykti in the first quarter, with execs saying they expect sales of the cell therapy to accelerate in

April 17, 2024

Ropirio Therapeutics secures exclusive license for novel lymphatic system activators

The Wyss Institute at Harvard University announced today that Ropirio Therapeutics, Inc. (Ropirio) has secured a worldwide, exclusive license from Harvard’s Office of Technology Development

September 11, 2024

Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

The Food and Drug Administration has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to

February 21, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.